Back to top
more

DaVita (DVA)

(Real Time Quote from BATS)

$149.79 USD

149.79
48,044

-0.17 (-0.11%)

Updated Aug 16, 2024 10:22 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 21% (52 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Founded in 1994 and headquartered in Denver, CO, DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services.

DaVita (DVA) Earnings and Revenues Beat Estimates in Q1

DaVita's (DVA) dialysis services in the United States showcased solid results in Q1.

DaVita HealthCare (DVA) Surpasses Q1 Earnings and Revenue Estimates

DaVita HealthCare (DVA) delivered earnings and revenue surprises of 25.34% and 0.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

What's in the Cards for DaVita (DVA)This Earnings Season?

DaVita (DVA) is expected to have gained from Kidney Care segment in Q1.

DaVita HealthCare (DVA) Reports Next Week: Wall Street Expects Earnings Growth

DaVita HealthCare (DVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks.com featured highlights include: DaVita, EchoStar and PennyMac Financial Services

Zacks.com featured highlights include: DaVita, EchoStar and PennyMac Financial Services

Should Value Investors Buy DaVita HealthCare (DVA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The Zacks Analyst Blog Highlights: InMode, Integer, Cardinal Health, DaVita and The Ensign Group

The Zacks Analyst Blog Highlights: InMode, Integer, Cardinal Health, DaVita and The Ensign Group

3 Momentum Anomaly Stocks to Consider Amid Coronavirus Woes

These fast movers are currently witnessing a short-term pullback in price as COVID-19 pandemonium batters market. So, this could essentially be a solid entry point for garnering profits.

Sejuti Banerjea headshot

5 Stocks to Buy for 5 Good Reasons

Here are 5 ways to make the most of a difficult market.

The Zacks Analyst Blog Highlights: DVA, CAH, TGNA, SLM and AMX

The Zacks Analyst Blog Highlights: DVA, CAH, TGNA, SLM and AMX

Coronavirus-Led Volatility Rises: 5 High Earnings Yield Picks

Dodge the COVID-19 pandemic by investing in these high earnings yield stocks.

Nalak Das headshot

5 Top Value Stocks to Buy in a Volatile April

Volatility is likely to persist in April as the panoptic impact of the coronavirus outbreak is yet to be realized in the United States and globally.

DVA or CHE: Which Is the Better Value Stock Right Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

Has DaVita (DVA) Outpaced Other Medical Stocks This Year?

Is (DVA) Outperforming Other Medical Stocks This Year?

DaVita HealthCare (DVA) Stock Moves -0.46%: What You Should Know

DaVita HealthCare (DVA) closed the most recent trading day at $76.06, moving -0.46% from the previous trading session.

Top Ranked Growth Stocks to Buy for March 31st

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 31st

Here's Why You Should Invest in DaVita (DVA) Stock Right Now

DaVita (DVA) continues to gain traction from strong international foothold, strategic buyout of dialysis centers and DaVita Kidney Care.

Zacks.com featured highlights include: ITOCHU, Am??rica M??vil, Donegal, DaVita and The Cardinal Health

Zacks.com featured highlights include: ITOCHU, Am??rica M??vil, Donegal, DaVita and The Cardinal Health

Nilanjan Choudhury headshot

Use Relative Price Strength to Survive the Coronavirus Hysteria

Want to try an out-of-the-box approach to earn handsome returns in the time of coronavirus? Tap these stocks with explosive relative price strength.

DaVita HealthCare (DVA) Gains As Market Dips: What You Should Know

DaVita HealthCare (DVA) closed at $75.27 in the latest trading session, marking a +0.19% move from the prior day.

DVA vs. CHE: Which Stock Should Value Investors Buy Now?

DVA vs. CHE: Which Stock Is the Better Value Option?

Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?

Is (DVA) Outperforming Other Medical Stocks This Year?

DaVita HealthCare (DVA) Down 12.2% Since Last Earnings Report: Can It Rebound?

DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Top Ranked Growth Stocks to Buy for March 10th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, March 10th

CVS Health's Latest Alliances to Fortify Kidney-Care Business

With a growing incidence of chronic kidney diseases and end-stage renal failure in the United States, CVS Health's (CVS) new partnerships seem to be strategic.